// App-Quantinova.ai

1246 : Development of STAT3 dual-targeting strategies for the treatment of pancreatic cancer

Researchers

Presenter

  • Melissa L. Fishel

Principal Investigators

  • Michelle L. Grimard

  • Mark R. Kelley

  • David A. Rosa

  • Andrew Shouksmith

  • Gary Tin

  • Ji Park

  • Patrick T. Gunning

Medical Centers

  • Indiana University, Indianapolis, IN

  • University of Toronto, Toronto, ON, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Signal transducer and activator of transcription 3

  • Signal transducer and activator of transcription 5

Drug/Treatment

  • Ruxolitinib phosphate

  • E-3330

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved